Consequently, decreased expression of NKG2D, NKp30, NKp46, and DNAM1 receptors was reported on NK cells in peripheral blood and tumor tissue of metastatic CRC patients (Zhang et al., 2012; Rocca et al., 2013, 2016; Ferretti et al., 2020). This evidence concerns the gene KLRK1 and neoplasm.